ch 14 - antimicrobial drugs Flashcards

1
Q

use of antimicrobials in ancient societies

A

there is evidence that humans have been exposed to antimicrobial compounds for millennia, not just in the last century
- antimicrobial properties of certain plants were also recognized by various cultures

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

ancient brewers tapped antibiotic secrets

A

ancient Egyptians and Jordanians used beer to treat gum disease and other ailments

a chemical analysis of the bones of ancient Nubians shows that they were regularly consuming tetracycline
- most likely in their beer
- this is the strongest evidence that the art of making antibiotics which dates to the discovery of penicillin in 1928, was common practice nearly 2,000 years ago

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

first antimicrobial drugs timeline

A

the first half of the 20th century was an era of strategic drug discovery

early 1900s
- Paul Ehrlich and his assistant Sahachiro Hata found compound 606
- killed Treponema pallidum
- sold under the name of Salvarsan

1928
- Alexander Fleming discovered penicillin, the first natural antibiotic

1930s
- Klarer, Mietzsch, and Domagk disovered prontosil
- killed streptococcal and staphylococcal infections
- the active breakdown product of prontosil is sulfanilamide
- Sulfanilamide was the first synthetic antimicrobial created

early 1940s
- Dorothy Hodgkin determined the structure of penicillin using x-rays
- scientists could then modify it to produce semisynthetic penicillins

1940s
- Selman Waksman’s research team discovered several antimicrobials produced by soil microorganisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

first antimicrobial drugs: early 1900s

A

Paul Ehrlich and his assistant Sahachiro Hata found compound 606
- sold under the name of Salvarsan

compound 606 (Salvarsan)
- kills Treponema pallidum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

first antimicrobial drugs: 1928

A

Alexander Fleming discovered penicillin
- first natural antibiotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

first antimicrobial drugs: 1930s

A

Klarer, Mietzsch, and Domagk disovered prontosil
- prontosil kills streptococcal and staphylococcal infections

prontosil’s active breakdown product is sulfanilamide
- sulfanilamide was the first synthetic antimicrobial created

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

first antimicrobial drugs: early 1940s

A

Dorothy Hodgkin determined the structure of penicillin using x-rays
- scientists could then modify it to produce semisynthetic penicillins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

first antimicrobial drugs: 1940

A

Selman Waksman’s research team discovered several antimicrobials produced by soil microorganisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

chemotherapeutic agent/drug

A

any chemical agent used in medical practice

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

antibiotic agent

A

usually considered to be a chemical substance made by a microorganism
- can inhibit the growth or kill microorganisms

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

antimicrobic/antimicrobial agent

A

a chemical substance similar to an antibiotic
- but may be synthetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

antibiotic

A

usually has one bacterial target
- e.g. a key bacterial enzyme is blocked

develops too rapidly to be sustainable
- targets more than just DNA/membranes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

antimicrobial

A

a broad term but often can mean multiple targets
- e.g. membranes and DNA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

selective toxicity

A

harms microbes but not damaging the host
- e.g. harming the cell wall

antibiotics exhibit selective toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

chemotherapeutic index

A

the ratio between toxic dose to therapeutic dose
- the higher the chemotherapeutic index, the safer the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

spectrum of antimicrobial activity

A

no single chemotherapeutic agent affects all microbes

antimicrobial drugs classified based on the type of organism they affect
- e.g. antibacterial, antifungal, etc

even within a group,
- one agent may have a narrow spectrum of activity
- whereas another many affect many species

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

types of spectrums of antimicrobial activity

A
  1. narrow spectrum
  2. broad spectrum
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

narrow spectrum of antimicrobial activity

A

targets only specific subsets of bacterial pathogens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

broad spectrum of antimicrobial activity

A

targets a wide variety of bacterial pathogens
- including Gram-positive and Gram-negative species

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

opportunistic pathogen

A

microbes that usually do not cause disease in healthy people
- may become virulent with immunocompromised and unhealthy individuals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

development of superinfections

A
  1. normal microbiota keeps opportunistic pathogens in check
  2. broad-spectrum antibiotics kill nonresistant cells
    - opportunistic pathogens still remain
  3. drug-resistant pathogens proliferate → can cause superinfection
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

types of antibiotic activity

A
  1. bacteriostatic
  2. bactericidal
  3. bacteriolytic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

bacteriostatic

A

having the ability to inhibit bacterial growth
- generally by means of chemical or physical treatment
- reversible inhibition of a microbe’s ability to divide

total cell count & viable cell count
- increases logarithmically until reaching a still level
- this limits growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

bacteriocidal

A

irreversible inhibition of a microbe’s ability to divide
- dead cells are not destroyed
- total cell numbers remain constant

graph:
- total cell count and viable cell count increase logarithmically
- total cell count then hits a standstill
- viable cell count decreases logarithmically at the same time, getting killed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

bacteriolytic

A

destruction or disintegration of bacteria
- lysis decreases both viable cell number & total cell number

graph:
- total cell count and viable cell count increase logarithmically
- then both decrease logarithmically over time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

in vitro effectiveness

A

the effectiveness of an agent in a test tube or artificial environment
- determined by how little of it is needed to stop growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

the in vitro effectiveness of an agent is determined by…

A

how little of it is needed to stop growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

how is in vitro effectiveness measured

A

in terms of the antibiotic’s minimal inhibitory concentration (MIC)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

minimal inhibitory concentration (MIC)

A

the lowest concentration of the drug that will prevent the growth of an organism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

minimal inhibitory concentration (MIC) reflects…

A

antibiotic efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

minimal bactericidal concentration (MBC)

A

lowest concentration of antibacterial agent required to kill bacterium over fixed time period
- determined by doing serial tube dilution for antibiotic

can distinguish if a drug is bactericidal or bacteriostatic
- e.g. if cells grow in fresh medium without antibiotic → drug is bacteriostatic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

determining minimum bactericidal concentration (MBC)

A

must use a serial tube dilution test for the antibiotic
- tubes with no visible growth are then inoculated onto agar media to determine MBC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

types of antibiotic activity tests

A
  1. Kirby-Bauer disk susceptibility test
  2. E-test
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

types of antibiotic activity: Kirby-Bauer disk susceptibility test

A

determines how susceptible a bacteria is to several antibiotics
- this is shown by the zone of inhibition
- cannot distinguish whether a drug is bacteriostatic or bactericidal

antibiotic diffuses from the circular disk into the agar
- interacts with the growing bacteria

zone of inhibition is measured around filter-paper disks impregnated with antibiotics
e.g. the oxacillin disk
- MRSA has no zone of clearing because MRSA is resistant
- versus MSSA which is not resistant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

types of antibiotic activity: E-test

A

determines MIC
- the intersection of the elliptical zone of clearing with the gradient on the drug containing strip indicates MIC
- cannot determine whether a drug is bacteriostatic or bactericidal

numbers on strip reflect the relative concentrations of antibiotic present at various points within the zone of inhibition
- the concentrations along the periphery of the clear zone are equal and reflect the MIC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

which test can distinguish whether the drug is bacteriostatic or bactericidal, the MIC test or the Kirby-Bauer test?

A

neither, need MBC to do this

must do serial tube dilution of antibiotic
- tubes with no visible growth are inoculated onto agar media without antibiotic to determine MBC

agar plate determines if any cells survived 3x-5x above the MIC
→ if cells grow: drug is bacteriostatic
→ if cells don’t grow: drug is bactericidal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

how to distinguish between bacteriostatic and bactericidal drugs

A

bacteriostatic
- if cells grow in the fresh medium without antibiotic

bactericidal
- if cells do not grow in the fresh medium without antibiotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

what are the 8 attributes of an ideal antimicrobial

A
  1. solubility
  2. selective toxicity
  3. toxicity not easily altered
  4. non-allergenic
  5. stability
  6. resistance by microorganisms not easily acquired
  7. long shelf-life
  8. reasonable cost
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

dosage

A

amount of medication given during a certain time interval
- route of administration must be considered
- half-life of antibiotic must be considered

in children
- dosage is based upon the patient’s mass

in adults
- a standard dosage is used, independent of mass

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

half-life of an antibiotic

A

the rate at which 50% of a drug is eliminated from the plasma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

half-life of a drug

A

the rate at which 50% of a drug stays in tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

when deciding which antibiotic to prescribe, the clinician needs to keep these three things in mind

A
  1. whether the organism is susceptible to the antibiotic
  2. whether the attainable tissue level of the antibiotic is higher than the MIC
    - depends on the body organs
  3. the understanding of the relationship between the therapeutic dose and the toxic dose of the drug
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

therapeutic dose

A

the minimum dose per kilogram of body weight that stops pathogen growth

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

toxic dose

A

the maximum dose that the patient can tolerate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

route of administration: plasma concentration of drug as a function of response time

A

routes of administration:
1. IV (intravenous)
- reach peak level of plasma concentration of a drug immediately after t0
- and the magnitude is greatest out of all 3

2. IM (intramuscular)
- reach peak level of plasma concentration of drug at t1
- magnitude around half of IV’s

3. oral
- reach peak level of plasma concentration of a drug shortly after t1
- magnitude slightly lower than IM

  • this is in relation to the chemotherapeutic index
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

combinations of antibiotics can either be

A
  1. synergistic
  2. antagonistic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

synergistic drugs may work poorly when…

A

they are given individually
- when combined, they work very well

combined effect is greater than additive effect
e.g. aminoglycoside + vancomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

antagonistic drugs may work poorly when…

A

they are combined with other antagonistic drugs
- mechanisms of actions will interfere with each other → diminish their effectiveness
e.g. penicillin + macrolides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

antibiotics exhibit selective toxicity because…

A

they disturb enzymes or structures unique to the target cell

mechanisms include:
1. cell wall synthesis
2. cell membrane integrity
3. DNA synthesis
4. RNA synthesis
5. protein synthesis
6. metabolism

50
Q

modes of action of antibiotics: targets of antibiotics

A
  1. cell wall
  2. plasma membrane
  3. DNA synthesis
  4. RNA synthesis
  5. ribosomes
  6. metabolic pathways
51
Q

antibiotics that target: cell wall

A

1. β-lactams
- penicillins
- cephalosporins
- monobactams
- carbapenems

2. glycopeptides
- vancomycin

3. bacitracin

52
Q

antibiotics that target: DNA synthesis

A

1. fluoroquinolones
- ciprofloxacin
- levofloxacin
- moxifloxacin

53
Q

antibiotics that target: RNA synthesis

A

1. rifamycins
- rifampin

54
Q

antibiotics that target: plasma membrane

A

1. polymyxins
- polymyxin B
- colistin

2. lipopeptide
- daptomycin

55
Q

antibiotics that target: ribosomes

A

30S subunit
- aminoglycosides
- tetracyclines

50S subunit
- macrolides
- lincosamides
- chloramphenicol
- oxazolidinones

56
Q

targets of antibiotics: metabolic pathways

A

folic acid synthesis
- sulfonamides
- sulfones
- trimethoprim

mycolic acid synthesis
- izoniazid

57
Q

antibiotics that target the cell wall: penicillins

A

the enzymes that attach the disaccharide units to preexisting peptidoglycan and produce peptide cross links
- collectively called penicillin-binding proteins (PBPs)

without an intact cell wall, the growing cell eventually bursts
- due to osmotic effects

penicillin is a bactericidal drug
- type of β-lactam antibiotic (has a β-lactam ring)

58
Q

antibiotics that target the cell wall: cephalosporins

A

β-lactam antibiotic originally discovered in nature but modified in the laboratory
- a type of semisynthetic drug

the basic structure of cephalosporin has been modified
- these modifications improve the drug’s effectiveness against penicillin-resistant pathogens

each modification is a new “generation” of cephalosporins
- there are currently 5 generations of this antibiotic

generation 1: Cephalexin
generation 2: Cefoxitin
generation 3: Ceftriaxone
generation 4: Cefepime
generation 5: Ceftaroline

59
Q

inhibitors of cell wall synthesis

A

polypeptide antibiotics
- bacitracin
- vancomycin

antimycobacterial antibiotics
- isoniazid (INH)
- ethambutol

60
Q

polypeptide antibiotics: bacitracin

A

topical application, works against Gram-positives
- form of inhibitor of cell wall synthesis

61
Q

polypeptide antibiotics: vancomycin

A

glycopeptide
- important “last line” against antibiotic-resistant S. aureus
- form of inhibitor of cell wall synthesis

62
Q

antimycobacterial antibiotics: isoniazid (INH)

A

inhibits mycolic acid synthesis
- form of inhibitor of cell wall synthesis

63
Q

antimycobacterial antibiotic: ethambutol

A

inhibits incorporation of mycolic acid
- form of inhibitor of cell wall synthesis

64
Q

microbial resistance to cell wall: inhibiting antibiotics

A

β-Lactamase (enzyme) is found in some bacteria
- it can break a bond in the β-lactam ring of penicillin → disables molecule

bacteria with β-Lactamase can resist the effects of penicillin
- and some other β-lactam antibiotics

Penicillin (w/ β-lactam ring) → (β-Lactamase) → Penicilloic acid

65
Q

antibiotics that target the bacterial membrane: polymyxin, tyrocidin, and platansimycin

A

act as detergents and disrupt the structure of the cell membrane
- done by binding to the phospholipids
- highly toxic
e.g. Platensimycin

mode of action
- interacts with lipopolysaccharide in the outer membrane of Gram-negative bacteria
- this kills the cell through the eventual disruption of the outer membrane and cytoplasmic membrane

66
Q

antibiotics that target the bacteria membrane: gramicidin

A

type of cyclic peptide

mode of action
- inserts into the cytoplasmic membrane of Gram-positive bacteria
- disrupting the membrane and killing the cell

67
Q

can bacterial DNA synthesis be a target for antibiotics?

A

yes, there are a few unique features of bacterial DNA synthesis that makes it a target for antibiotics

68
Q

antibiotics that affect DNA synthesis and integrity: metronidazole

A

metronidazole is activated after being metabolized by microbial protein cofactors ferredoxin
- ferredoxin is found in anaerobic and microaerophilic bacteria such as Bacterioides and Fusobacterium

aerobic microbes are resistant
- this is because they do not possess the electron transport proteins capable of reducing metronidazole

prodrug form of metronidazole → (single e- transfers) → nitrous free-radical form of metronidazole

69
Q

antibiotics that affect DNA synthesis and integrity: sulfonamides

A

sulfonamide (sulfa) drugs act to inhibit the synthesis of folic acid
- folic acid is an important cofactor in the synthesis of nucleic acid precursors

all organisms use folic acid to synthesize nucleic acids
- bacteria make folic acid from the combination of PABA, glutamic acid, and pteridine
- mammals do not synthesize folic acid and must get it from the diet or microbes

PABA: para-aminobenzoic acid
SFA: sulfanilamide

70
Q

normal folic acid formation versus formation blocked by sulfanilamide (SFA)

A

sulfanilamide (SFA) is a type of sulfonamide drug
- inhibits the synthesis of folic acid

normal folic acid formation
- P, PABA, G all enter the enzyme and synthesis occurs → folic acid

folic acid formation blocked by sulfanilamide (SFA)
- P, SFA, G all enter the enzyme → no synthesis occurs → P, SFA, G all leave the enzyme

SFA enters the enzyme in place of PABA
- PABA is needed for folic acid synthesis

71
Q

antibiotics that affect DNA synthesis and integrity: quinolones

A

DNA gyrase bound to and inactivated by a quinolone will block progression of a DNA replication fork

bacterial DNA gyrases are structurally distinct from their mammalian counterparts…
- quinolone antibiotics will not affect mammalian DNA replication

72
Q

RNA synthesis inhibiting antibiotics: rifampin (rifamycin)

A

rifampin is the best known member of the rifamycin family of antibiotics
- selectively binds to bacterial RNA polymerase and prevents transcription

rifampin is also used to treat tuberculosis and meningococcal meningitis

73
Q

antibiotics that inhibit protein synthesis: mode of action

A

the major classes of protein synthesis inhibitors target the 30S or 50S subunits of cytoplasmic ribosomes

74
Q

antibiotics that inhibit protein synthesis: drugs that affect the 30S ribosomal subunit

A
  1. aminoglycosides
    - streptomycin, gentamicin, tobramycin
  2. tetracyclines
    - doxycycline
  3. glycylcyclines
    - tigecycline
75
Q

antibiotics that inhibit protein synthesis: aminoglycosides

A

causes misreading of mRNA and inhibits peptidyl-tRNA translocation

aminoglycosides in particular:
- streptomycin
- gentamicin
- tobramycin

affects the 30S ribosomal subunit

76
Q

antibiotics that inhibit protein synthesis: tetracyclines

A

binds to the 30S subunit and prevent tRNAs carrying amino acids from entering the A site

tetracycline in particular:
- doxycycline

affects the 30S ribosomal subunit

77
Q

antibiotics that inhibit protein synthesis: glycylcyclines

A

binds to the 30S subunit and inhibits the entry of aminoacyl-tRNA into the A site
- it is able to function in tetracycline resistant cells

glycylcycline in particular:
- tigecycline

affects the 30S ribosomal subunit

78
Q

antibiotics that inhibit protein synthesis: drugs that affect the 50S ribosomal subunit

A
  1. chloramphenicol
  2. macrolides
    - erythromycin
    - azithromycin
    - clarithromycin
  3. lincosamides
    - clindamycin
  4. oxazolidinones
  5. streptogramins
    - quinupristin, dalfopristin
79
Q

antibiotics that inhibit protein synthesis: chloramphenicol

A

prevents peptide bond formation
- done by inhibiting peptidyltransferase in the 50S subunit

affects the 50S ribosomal subunit

80
Q

antibiotics that inhibit protein synthesis: macrolides

A

binds to 50S subunit and inhibit translocation of tRNA from the A site to the P site

further broken down into:
- erythromycin
- azithromycin
- clarithromycin

affects the 50S subunit of ribosomes

81
Q

antibiotics that inhibit protein synthesis: lincosamides

A

binds to peptidyltransferase and prevents peptide bond formation from the ribosome

further broken down into:
- clindamycin

affects the 50S subunit of ribosomes

82
Q

antibiotics that inhibit protein synthesis: oxazolidinones

A

binds to 50S subunit and prevent assembly of the 70S ribosome

affects the 50S subunit of ribosomes

83
Q

antibiotics that inhibit protein synthesis: streptogramins

A

bind to 50S subunit and block tRNA entry into the A site
- while blocking exit of a growing protein from the ribosome

further broken down into:
- quinupristin
- dalfopristin

affects the 50S subunit of ribosomes

84
Q

mechanisms of drug resistance

A
  1. drug modification or inactivation
  2. blocked penetration
  3. efflux pumps
  4. target modification
  5. target overproduction
  6. enzymic bypass
  7. target mimicry
85
Q

mechanisms of drug resistance: drug modification or inactivation

A

enzymes can be coded by genes that can chemically modify an antimicrobial
- which inactivates it
- or can destroy an antimicrobial through hydrolysis

inactivation of enzymes can affect:
- β-lactams
- aminoglycosides
- macrolides
- rifamycins

86
Q

mechanisms of drug resistance: blocked penetration

A

altering porins in the outer membrane

blocked penetration can affect:
- β-lactams
- tetracyclines
- fluoroquinolones

e.g. (for understanding only)
- a common mechanism of carbapenem resistance among P. aeruginosa is to decrease amount of OprD porin
- which is the primary portal of entry for carbapenems

87
Q

mechanisms of drug resistance: efflux pump

A

transport proteins that allow microorganisms to regulate their internal environment by removing toxic substances
- can export multiple antimicrobial drugs
- prevents the accumulation of drug to a level that would be antibacterial

efflux pump can affect:
- fluoroquinolones
- aminoglycosides
- tetracyclines
- β-lactams
- macrolides

88
Q

mechanisms of drug resistance: target modification

A

antimicrobial drugs have very specific targets
- structural changes to those targets can prevent drug binding
- this renders the drug ineffective

mechanism allows a formerly inhibited reaction to occur
- e.g. for understanding only: penicillin-binding proteins (PBPs) can inhibit the binding of β-lactam drugs and provide resistance to multiple drugs within this class

target modification can affect:
- fluoroquinolones
- rifamycins
- vancomycin
- β-lactams
- macrolides
- aminoglycosides

89
Q

mechanisms of drug resistance: target overproduction

A

microbe overproduces the target enzyme
- such that there is a sufficient amount of antimicrobial-free enzyme to carry out the proper enzymatic reaction

90
Q

mechanisms of drug resistance: enzymatic bypass

A

microbe develops a bypass that circumvents the need for the functional target enzyme

blocks the pathway with the functional target enzyme
- alternate route is used

91
Q

mechanisms of drug resistance: target mimicry

A

production of proteins that bind and sequester drugs
- preventing the drugs from binding to their bacterial cellular target

92
Q

fighting drug resistance

A

dummy target compounds that inactivate resistance enzymes have been developed

e.g.
- Clavulanic acid binds and ties up β-lactamases secreted from penicillin resistant bacteria

93
Q

individuals can take the following actions to help fight drug resistance

A
  • frequent hand washing
  • vaccinations
  • avoiding use of antibiotics for viral infections
  • refusing leftover antibiotics
  • take full course of antibiotics prescribed
94
Q

fighting drug resistance: effects of taking full course of antibiotics prescribed

A

day 0:
- highly sensitive organisms: moderate amount
- intermediate organisms: large amount
- highly resistant organisms: moderate amount
→ graph resembles a bell curve

day 3:
- highly sensitive organisms: low amount
- intermediate organisms: moderate amount
- highly resistant organisms: moderate amount

day 6:
- highly sensitive organisms: low amount
- intermediate organisms: low amount
- highly resistant organisms: moderate amount

day 10 (antibiotics are stopped prematurely):
- highly sensitive organisms: low amount
- intermediate organisms: low amount
- highly resistant organisms: high amount
→ relapse with resistant organisms
→ resistant organisms can also spread to other hosts, causing more drug-resistant infections

day 10 (full course of antibiotic treatment finished):
- low amount of all types of organisms
- end of successful treatment

95
Q

components of the influenza virus

A

hemagglutinin and neuraminidase
- influenza virus must be treated with antiviral agents that prevent virus uncoating or release

96
Q

hemagglutinin

A

binds to the host membrane receptors for entry by phagocytosis
- component of the influenza virus

97
Q

neuraminidase

A

cleaves sialic acid to allow virus particles to escape from infected cells
- component of the influenza virus

98
Q

antiviral agents that prevent virus uncoating or release

A
  • amantadine
  • oseltamivir (Tamiflu)
  • zanamivir (Relenza)
99
Q

antiviral agents: amantadine

A

prevents the virus from uncoating and exiting by changing the pH of the phagolysosome

100
Q

antiviral agents: oseltamivir (Tamiflu) & zanamivir (Relenza)

A

neuraminidase inhibitors prevent the virus particles from leaving the cell

101
Q

antiviral DNA and RNA synthesis inhibitors

A
  1. zidovudine
  2. acyclovir
  3. deoxyribonucleotide containing thymine
  4. deoxyguanosine
102
Q

antiviral agents: types of nucleoside and nonnucleoside reverse transcriptase inhibitors

A
  1. protease inhibitors
    - Nelfinavir (Viracept)
    - Iopinavir (Kaletra)
  2. entry inhibitors
    - CCR5 inhibitors (maraviroc)
103
Q

nucleoside and nonnucleoside reverse transcriptase inhibitors: protease inhibitors

A

targets the HIV protease enzyme
- Nelfinavir (Viracept)
- Iopinavir (Kaletra)

104
Q

nucleoside and nonnucleoside reverse transcriptase inhibitors: entry inhibitors

A

block virus envelope protein gp120 from binding to the host receptor CCR5
- CCR5 inhibitors (maraviroc)

105
Q

antifungal agents

A
  1. polyenes
    - nystatin, amphotericin B
  2. azoles
    - imidazoles, triazoles
  3. allylamines
    - terbinafine, lamisil
  4. echinocandins
    - caspofungin
  5. griseofulvin
  6. flucytosine
106
Q

antifungal agents: polyenes

A

disrupts membrane integrity
- nystatin
- amphotericin B

107
Q

antifungal agents: azoles

A

interferes with ergosterol synthesis
- imidazoles
- triazoles

108
Q

antifungal agents: allylamines

A

interferes with ergosterol synthesis
- terbinafine
- lamisil

109
Q

antifungal agents: echinocandins

A

blocks fungal cell wall synthesis
- caspofungin

110
Q

antifungal agents: griseofulvin

A

blocks cell division

111
Q

antifungal agents: flucytosine

A

inhibits DNA synthesis

112
Q

antiparasitic agents include

A
  • antiprotozoan agents
  • antihelminthic agents
113
Q

antiprotozoan agents

A

most are fairly toxic
- metronidazole
- quinine
- chloroquinine, primaquine (antimalarials)

114
Q

antiprotozoan agents: metronidazole

A

causes DNA breakage
- used to treat giardisis and Trichomonas infections

115
Q

antiprotozoan agents: quinine

A

commonly used in the past
- now used as a last resort to treat malaria

116
Q

antiprotozoan agents: chloroquinine & primaquine

A

interfere with protein synthesis
- specially RBCs
- these are antimalarials

117
Q

antihelminthic agents

A
  1. niclosamide
    - tapeworms
  2. praziquantel
    - flatworms
  3. mebendazole and albendazole
    - intestinal roundworms
  4. ivermectin
    - intestinal roundworms
118
Q

antihelminthic agents: niclosamide

A

prevents ATP generation
- targets tapeworms

119
Q

antihelminthic agents: praziquantel

A

alters membrane permeability
- targets flatworms

120
Q

antihelminthic agents: mebendazole and albendazole

A

interferes with nutrient absorption
- targets intestinal roundworms

121
Q

antihelminthic agents: ivermectin

A

causes paralysis of helminths
- targets intestinal roundworms